Marex Group PLC Aclaris Therapeutics, Inc. Transaction History
Marex Group PLC
- $11.1 Billion
- Q2 2025
A detailed history of Marex Group PLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Marex Group PLC holds 14,400 shares of ACRS stock, worth $28,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,400Holding current value
$28,943% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
100Shares Held
88.3MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$28.6 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$19.4 Million0.02% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$17.9 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$13.4 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$9.59 Million0.46% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $134M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...